AMR Industry Alliance Round-Up, Issue No.2, September 2019

Welcome to the second issue of the Alliance Round-Up – written for more than 100 biotech, diagnostic, generic and R&D pharma companies that are members of the AMR Industry Alliance, as well as people interested in collaborating with the alliance to combat antimicrobial resistance. Through this newsletter, we aim to share news, updates and expert opinions […]

New brochure to discover the AMR Industry Alliance in 2 minutes

Representing more than 100 biotechnology, diagnostics, generics and research-based pharmaceutical companies and associations, the AMR Industry Alliance is one of the largest private sector coalitions set up to provide sustainable solutions to the global antimicrobial resistance (AMR) crisis. Discover our mission to stand united against antimicrobial resistance in our new Brochure.

AMR Industry Alliance Round-Up, Issue No.1, June 2019

  This is the first issue of “Alliance Round-Up” written for the more than 100 biotech, diagnostic, generic and pharma companies who are members of the AMR Industry Alliance, as well as people interested in collaborating with the Alliance to accelerate efforts to combat antimicrobial resistance. In the Alliance Round-Up, we will provide updates and […]

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance (AMR) has made strides in 2018 and calls for a coordinated and multi-pronged response from all stakeholders The AMR Industry Alliance has made major strides in 2018 taking action across four different areas to tackle the public health threat of AMR: research […]

Multiple Alliance Members Co-sign the Canadian Declaration on Antimicrobial Resistance

The International Council of Biotechnology Associations (ICBA) supports the Canadian Declaration on Combatting Antimicrobial Resistance, signed by biopharmaceutical and diagnostic companies in Canada and released today in conjunction with the opening of the G7 Summit in Charlevoix, Quebec. “Since the Industry Declaration at Davos was signed in 2016, the issue of antimicrobial resistance has only grown […]

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The report measures action taken in four areas: research and science, access, appropriate use, and the environment. In 2016, the report shows that 22 Alliance companies invested at least USD […]

New Alliance to Drive and Measure Industry Progress to Curb Antimicrobial Resistance

New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance. The AMR Industry Alliance will ensure that signatories collectively deliver on the commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and will measure industry’s progress in the fight […]

AMR Roadmap Launched

Leading Pharmaceutical Companies Present Industry Roadmap to Combat Antimicrobial Resistance Comprehensive roadmap lays out key commitments the pharmaceutical companies pledge to deliver by 2020 to reduce antimicrobial resistance Represents major milestone following the Industry Declaration signed in January 2016 at the World Economic Forum by more than 100 companies and trade associations NEW YORK, N.Y., […]

AMR Declaration Launched

More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well as key industry bodies, have come together to call on governments and industry to work in parallel in taking comprehensive action against drug-resistant infections – so-called ‘superbugs’ – with a joint declaration launched today at the World Economic Forum in Davos, Switzerland. […]